Finding order
in nature

Patent Estate

We own or exclusively license a patent estate comprising over 80 issued or allowed patents and over 230 pending patent applications, including over 300 potential Physiocrine-based protein compositions.

In addition to patent protection, we also rely on trade secrets and careful monitoring of our proprietary information to protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection.

We also rely on know-how, continuing technological innovation and in-licensing opportunities to develop, strengthen, and maintain our proprietary position in the field of Physiocrine therapeutics.

© 2007 - 2017   aTyr Pharma.   Legal   Privacy Policy